CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen
Clinical trial NCT05312398 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05312398
- Sponsor
- University of Campania Luigi Vanvitelli
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2026-08-15
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.